Founded with a mission to revolutionize respiratory disease treatment, Beyond Air, Inc. is a medical device and biopharmaceutical company operating in the United States and Israel. The company focuses on the discovery and development of nitric oxide formulations and delivery systems, primarily through its LungFit® technology, which generates unlimited, on-demand nitric oxide from room air without the need for cylinders. Beyond Air aims to provide innovative, hassle-free solutions for both hospital and home settings, enhancing patient care and expanding treatment options.

Notable figures affiliated with Beyond Air include David Webster, who serves as the Chief Commercial Officer. The company has achieved significant milestones, such as presenting first-in-class clinical data demonstrating an immunogenic response in subjects with unresectable solid tumors. Beyond Air's impact lies in its pioneering approach to nitric oxide therapy, which has the potential to transform respiratory disease management and improve patient outcomes globally.